Virax Holdings Limited ASX: VHL - Commencement of Phase II US trials - Dr David Beames, CEO
Sydney, Nov 20, 2006 (ABN Newswire) - Virax Holdings Limited (ASX: VHL) - Commencement of Phase II US trials - Dr David Beames, CEO; Boardroomradio is pleased to announce that Virax Holdings Limited (ASX: VHL) has published an audio file. The following presentation "Commencement of Phase II US trials" is now available as an instant audio download to your computer. You may also transfer this information to your listening device as an IPod podcast.
The BRR service is based on streaming audio sent in compressed form over the internet and displayed as it arrives. You do not have to wait for the whole file to be downloaded before you can hear it, instead the media is sent in a continuous stream and is played immediately as it reaches your computer. Please note that during live broadcasts there can be a delay of approximately 1-2 minutes, depending on traffic through your Internet Service Provider.
Broadcaster: Virax Holdings Limited (ASX: VHL)
Broadcast Title: Commencement of Phase II US trials
Broadcast Type: Audio stream
View the Audio stream for Virax Holdings Limited (ASX: VHL) below.
Bio-pharmaceutical research and development investment.
About Boardroomradio
Sydney-based Boardroomradio (BRR) is an Investor Relations multi-media portal delivering audio webcasts to the investment community, including brokers, fund managers, analysts, and private investors.
